Dieses Bild zeigt Wilhelm K. Aicher

Wilhelm K. Aicher

Herr Prof. Dr. rer.nat.

Doktorand*Innen-Betreuer Tübingen
Eberhard Karls Universität Tübingen
Universitätsklinikum, Thorax-, Herz- und Gefäßchirurgie
[Foto: Wilhelm Aicher]

Kontakt

+49 7071 2987020

Hoppe-Seyler-Strasse 3
72076 Tübingen
Deutschland

  1. 2022

    1. N. Harland u. a., „Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation“, International Journal of Molecular Sciences, Bd. 23, Nr. 9, Art. Nr. 9, 2022, doi: 10.3390/ijms23094969.
    2. L. Becker u. a., „Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids“, International Journal of Molecular Sciences, Bd. 23, Nr. 13, Art. Nr. 13, 2022, doi: 10.3390/ijms23136956.
    3. Y. Wei u. a., „Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems“, International Journal of Molecular Sciences, Bd. 23, Nr. 11, Art. Nr. 11, 2022, doi: 10.3390/ijms23116305.
    4. R. Geng u. a., „CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?“, International Journal of Molecular Sciences, Bd. 23, Nr. 10, Art. Nr. 10, 2022, doi: 10.3390/ijms23105453.

  2. 2021

    1. N. Harland u. a., „Organoide zur Weiterentwicklung der intraoperativen Diagnostik“, Der Urologe, Bd. 60, Nr. 9, Art. Nr. 9, Sep. 2021, doi: 10.1007/s00120-021-01595-5.

Akademische Ausbildung und beruflicher Werdegang

  • 1980 - 1985 Studies in Biochemistry and Physiological Chemistry at the University of Tübingen and at Ludwigs-Maximilians University, Munich
  • 1985 - 1986 Diploma Thesis, University of Tübingen and Max-Planck Institute for Developmental Biology, Tübingen
  • 1986 - 1989 PhD student at Max-Planck Institute for Biology, Tübingen
  • 1987 - 1989 Research Fellow, Department of Microbiology, University of Alabama at Birmingham (UAB), Birmingham, AL. USA
  • 1990 PhD, Faculty of Biology at University of Tübingen
  • 1990 - 1991Research Associate, Division of Rheumatology, WHO Rheumatology Research Center at UAB, Birmingham, AL. USA
  • 1992 - 1996 Research Assistant, Clinical Rheumatology Research Group University of Freiburg Hospital, Freiburg
  • 1997 - 2011 Head of Research Laboratory, Dept. of Orthopopedic Surgery University of Tübingen Hospital, Tübingen
  • 1999 Habilitation and venia legendi at Faculty of Medicine, Eberhard-Karls University, Tübingen
  • 2005 - 2013 Assoc. Prof. for Molecular Medicine (apl. Prof.), Centre for Medical Research, University of Tübingen Medical School 2006 - 2011 Deputy Director, Centre for Regeneration Biology and Medical Technology, at University of Tübingen
  • 2006 - 2011 Deputy Director, Centre for Regeneration Biology and Medical Technology, at University of Tübingen
  • 2012 - 2015 Head of KFO273, Medical Faculty, Eberhard-Karls University, Tübingen
  • 2013 - 2017 Coordinator of COST Action BM1209 Regenerative Sphincter Therapy ( ReST ) 
  • 2014 - present Professor for Experimental Urology, Head of Research Laboratories, Dept. of Urology, University of Tübingen Hospital
  • 2017 - 2020 Management Committee, COST Action ENIUS; file # CA16217) 
Zum Seitenanfang